We are live on ! Find out more
TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+18.15%
3 Year Est. Return
+62.51%
5 Year Est. Return
+140.53%
10 Year Est. Return
+502.91%
AUM
$2.91B
AUM Growth
+$61.2M
Cap. Flow
+$64.4M
Cap. Flow %
2.22%
Top 10 Hldgs %
30.43%
Holding
226
New
26
Increased
31
Reduced
48
Closed
30

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$41M
2
ABT icon
Abbott
ABT
+$37M
3
MRNA icon
Moderna
MRNA
+$32.5M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$29.2M
5
GILD icon
Gilead Sciences
GILD
+$26.5M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$60.5M
2
BDX icon
Becton Dickinson
BDX
+$22.1M
3
HUM icon
Humana
HUM
+$18.1M
4
TECH icon
Bio-Techne
TECH
+$16.1M
5
NVCR icon
NovoCure
NVCR
+$15.2M

Sector Composition

Rank Sector Weight
1 Healthcare 95.75%
2 Real Estate 2.99%
3 Industrials 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PVLA
151
Palvella Therapeutics
PVLA
$2.02B
$2.63M 0.09%
12,792
-5,324
-29% -$1.16M
MLTX icon
152
MoonLake Immunotherapeutics
MLTX
$1.48B
$2.56M 0.09%
250,000
– –
MTEM
153
DELISTED
Molecular Templates, Inc.
MTEM
$2.52M 0.09%
13,295
-1,360
-9% -$238K
PRAX icon
154
Praxis Precision Medicines
PRAX
$8.52B
$2.46M 0.08%
5,000
– –
SRRK icon
155
Scholar Rock
SRRK
$5.49B
$2.42M 0.08%
47,869
-68,225
-59% -$3.77M
HOLX
156
DELISTED
Hologic
HOLX
$2.42M 0.08%
32,564
– –
GMAB icon
157
Genmab
GMAB
$17.6B
$2.4M 0.08%
73,015
-185,657
-72% -$6.98M
XRN
158
Chiron Real Estate Inc
XRN
$467M
$2.29M 0.08%
34,979
– –
AFMD
159
DELISTED
Affimed
AFMD
$2.28M 0.08%
28,802
+2,000
+7% +$130K
HRTX icon
160
Heron Therapeutics
HRTX
$96.8M
$2.13M 0.07%
131,183
– –
PRGO icon
161
Perrigo
PRGO
$1.48B
$2.07M 0.07%
51,224
– –
HR icon
162
Healthcare Realty
HR
$7.12B
$1.95M 0.07%
70,662
– –
MOR
163
DELISTED
MorphoSys AG American Depositary Shares
MOR
$1.78M 0.06%
81,867
– –
ICPT
164
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.78M 0.06%
77,067
– –
DRNA
165
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.74M 0.06%
68,150
– –
ZGNX
166
DELISTED
Zogenix, Inc.
ZGNX
$1.74M 0.06%
88,977
– –
DHC
167
Diversified Healthcare Trust
DHC
$2.13B
$1.71M 0.06%
357,720
– –
SNR
168
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$1.6M 0.05%
256,398
– –
CYH icon
169
Community Health Systems
CYH
$412M
$1.59M 0.05%
117,535
-200
-0.2% -$1.96K
MDGL icon
170
Madrigal Pharmaceuticals
MDGL
$11.1B
$1.56M 0.05%
13,340
– –
OVID icon
171
Ovid Therapeutics
OVID
$435M
$1.5M 0.05%
372,733
– –
KALV
172
DELISTED
KalVista Pharmaceuticals
KALV
$1.28M 0.04%
+50,000
New +$1.31M
ONEM
173
DELISTED
1Life Healthcare
ONEM
$1.22M 0.04%
+31,266
New +$1.47M
XLV icon
174
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$1.17M 0.04%
10,055
– –
ASRT
175
DELISTED
Assertio
ASRT
$1.12M 0.04%
27,372
– –
5 6
7
8 9

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
BWM
BerganKDV Wealth Management Bloomington, Minnesota $1,000M AUM 9.95% 1-Year Est. Return

Tekla Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Tekla Capital Management held 226 positions worth $2.91B, up 2.1% from $2.85B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Tekla Capital Management's Q1 2021 filing shows 26 new, 31 increased, 48 reduced and 30 closed positions. Its largest new stake was Universal Health Services: 71,323 shares worth $9.51M. The largest sale was Alexion Pharmaceuticals, an estimated $60.5M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Real Estate and Industrials.

  • Tekla Capital Management's largest Q1 2021 buy was Universal Health Services: 71,323 shares worth $9.51M.
  • Tekla Capital Management added most to Elevance Health in Q1 2021, an estimated $41M increase.
  • Tekla Capital Management's biggest Q1 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $60.5M.
  • Tekla Capital Management fully exited NovoCure in Q1 2021, selling an estimated $15.2M.
  • Tekla Capital Management's ten largest holdings make up 30% of its $2.91B portfolio in Q1 2021.
  • Tekla Capital Management opened 26 new positions and closed 30 in Q1 2021.
  • Tekla Capital Management's portfolio value rose 2.1% quarter-over-quarter to $2.91B.

Based on Tekla Capital Management's 13F filing for Q1 2021, filed 14 May 2021.